Breakwater Capital Group’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$239K	Buy	17,096 +2,081	+14%	+$29.1K	0.04%	311
2025 Q1	$204K	Buy	+15,015	New	+$204K	0.04%	320
2024 Q4	–	Sell	-7,642	Closed	-$223K	–	289
2024 Q3	$223K	Buy	+7,642	New	+$223K	0.04%	269